Key result
Homozygous MGME1 variant linked to progressive dilated cardiomyopathy requiring successful heart transplantation.
This report expands the clinical spectrum of MGME1-related mitochondrial disease to include dilated cardiomyopathy requiring heart transplantation and highlights the importance of periodic genomic data reanalysis.
MGME1-related disease may include severe dilated cardiomyopathy; extends phenotypic spectrum but remains hypothesis-generating.
We report two siblings harboring a homozygous MGME1 variant, NM_052865.4:c.818 T>A; p.(Val273Glu), both presenting with ptosis, myopathy, scoliosis, and gastrointestinal symptoms. The index patient developed progressive, medically refractory dilated cardiomyopathy and underwent successful orthotopic heart transplantation (OHT). Reanalysis of previously negative WES identified the variant in the index case, and segregation by Sanger sequencing confirmed homozygosity in both siblings. Although several clinical findings overlap with previously described MGME1 ‐related disease, the detected variant remains classified as a variant of uncertain significance (VUS); thus, functional evidence is needed to better understand its potential causal relevance. Additionally, this report underscores the importance of periodic genomic data reanalysis and highlights the variable expressivity that may occur even within the same family.
No takes yet. Share an insight, caveat, or question.
Acikgoz et al. (2026) studied this question. A homozygous MGME1 variant was identified in Turkish siblings, with one sibling successfully undergoing heart transplantation due to progressive dilated cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: